PTCA balloon catheter

DEVICE2 trials

Sponsors

UMC Utrecht, Boston Scientific Corporation

Conditions

AtherosclerosisCoronary Artery DiseaseIn-Stent RestenosisStable AnginaUnstable Angina

Phase 2

Drug-eluting Balloon in Bifurcations Trial

CompletedNCT00857441

UMC UtrechtAtherosclerosis, Coronary Artery Disease, Stable Angina +1

Start: 2008-01-31End: 2015-01-31Updated: 2015-07-20

Phase 3

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

Active, not recruitingNCT04647253

Boston Scientific CorporationIn-Stent Restenosis

Start: 2021-05-11End: 2027-09-01Updated: 2026-03-23

Related Papers

Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial.

2026-01-19

Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial.

2025-11-01

Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis

Journal of the American College of Cardiology2025-08-014 citations

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis

JAMA2024-03-09111 citations